U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
leronlimab [INN]
Preferred Name English
LERONLIMAB
INN   USAN  
Official Name English
PRO-140
Code English
LERONLIMAB [USAN]
Common Name English
Leronlimab [WHO-DD]
Common Name English
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS C-C CHEMOKINE RECEPTOR TYPE 5 (CCR5, ANTIGEN CD195))HUMANIZED MONOCLONAL ANTIBODY.GAMMA.4 HEAVY CHAIN (1-449) (HUMANIZED VH (HOMO SAPIENS IGHV3-15*06 (72%) (IGHD)-IGHJ5*01 (87%)) (8.8.15) (1-122) -HOMO SAPIENS
Systematic Name English
IMMUNOGLOBULIN G4, ANTI-(HUMAN CHEMOKINE RECEPTOR CCR5) (HUMANIZED MONOCLONAL PRO 140 .GAMMA.4-CHAIN), DISULFIDE WITH HUMANIZED MONOCLONAL PRO 140 .KAPPA.-CHAIN, DIMER
Systematic Name English
PRO140
Code English
Classification Tree Code System Code
FDA ORPHAN DRUG 516516
Created by admin on Tue Apr 01 21:24:36 GMT 2025 , Edited by admin on Tue Apr 01 21:24:36 GMT 2025
Code System Code Type Description
FDA UNII
Y1J4NP8FF0
Created by admin on Tue Apr 01 21:24:36 GMT 2025 , Edited by admin on Tue Apr 01 21:24:36 GMT 2025
PRIMARY
WIKIPEDIA
Leronlimab
Created by admin on Tue Apr 01 21:24:36 GMT 2025 , Edited by admin on Tue Apr 01 21:24:36 GMT 2025
PRIMARY
SMS_ID
100000181761
Created by admin on Tue Apr 01 21:24:36 GMT 2025 , Edited by admin on Tue Apr 01 21:24:36 GMT 2025
PRIMARY
CAS
674782-26-4
Created by admin on Tue Apr 01 21:24:36 GMT 2025 , Edited by admin on Tue Apr 01 21:24:36 GMT 2025
PRIMARY
INN
10751
Created by admin on Tue Apr 01 21:24:36 GMT 2025 , Edited by admin on Tue Apr 01 21:24:36 GMT 2025
PRIMARY
DRUG BANK
DB05941
Created by admin on Tue Apr 01 21:24:36 GMT 2025 , Edited by admin on Tue Apr 01 21:24:36 GMT 2025
PRIMARY
NCI_THESAURUS
C137824
Created by admin on Tue Apr 01 21:24:36 GMT 2025 , Edited by admin on Tue Apr 01 21:24:36 GMT 2025
PRIMARY
USAN
FG-09
Created by admin on Tue Apr 01 21:24:36 GMT 2025 , Edited by admin on Tue Apr 01 21:24:36 GMT 2025
PRIMARY
ACTIVE MOIETY
LERONLIMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966